Teva Presents New Reslizumab Data at ERS International Congress 2015 By: Benzinga via Benzinga September 27, 2015 at 06:38 AM EDT Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today presented results from a post hoc analysis of two pivotal ... Read More >> Related Stocks: Teva Pharmaceutical Industries ADR